Last reviewed · How we verify
African trypanosomiasis
Approved treatments
- Pentam · Fresenius Kabi
Pentamidine works by interfering with the reproduction of certain parasites, such as Pneumocystis jiroveci. - Vaniqa
Eflornithine inhibits ornithine decarboxylase, reducing polyamine synthesis and affecting cancer cell growth and metabolism. - Arsobal
Arsobal works by inhibiting the enzyme dihydrofolate reductase in the parasite, disrupting its ability to synthesize DNA and ultimately leading to its death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- African trypanosomiasis patent landscape — cliff calendar, originator estates, attackable patents
- African trypanosomiasis treatment landscape brief
- African trypanosomiasis treatment updates RSS
Frequently asked questions about African trypanosomiasis
What drugs treat African trypanosomiasis?
Tracked treatments include Pentam, Vaniqa, Arsobal.
What is the treatment for African trypanosomiasis?
Standard treatment for African trypanosomiasis includes Pentam, Vaniqa, Arsobal. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: African trypanosomiasis patent cliff · African trypanosomiasis CI report
- Treatment: Pentam · Fresenius Kabi
- Treatment: Vaniqa
- Treatment: Arsobal
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing